サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606537

外科用メッシュの世界市場-2024～2031年

Global Surgical Mesh Market - 2024-2031

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
外科用メッシュの世界市場-2024～2031年
出版日: 2024年12月04日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

外科用メッシュの世界市場は、2023年に19億米ドルに達し、2031年には32億2,000万米ドルに達すると予測され、予測期間2024年～2031年のCAGRは6.9%で成長する見込みです。

外科用メッシュは、外科手術で弱った組織や損傷した組織に追加的な支持を与えるために使用される医療機器です。一般的には、合成材料または生物学的材料で作られた柔軟なシート状の構造であり、治癒中の組織を補強し安定させるように設計されています。外科用メッシュは、ヘルニア修復、骨盤臓器脱（POP）修復、ストレス性尿失禁（SUI）治療、その他の再建手術など、さまざまな外科的用途で広く使用されています。メッシュには、モノフィラメント、マルチフィラメント、複合メッシュなど、さまざまな構造のものがあり、特定の外科的ニーズに対応しています。

外科用メッシュ市場は、特にヘルニア手術の増加により、長年にわたって大きな需要を目の当たりにしてきました。例えば、米国食品医薬品局（FDA）によると、米国では毎年100万件以上のヘルニア手術が行われており、世界全体では年間2,000万件以上の手術が行われていると推定されています。これらの手術には外科用メッシュが使用されており、ヘルニア手術の標準治療となっているため、外科用メッシュの需要増加に寄与しています。

市場力学：

促進要因と抑制要因

ヘルニアの有病率の上昇

ヘルニアの有病率の上昇は、外科用メッシュ市場を大きく牽引しています。ヘルニアの修復は、メッシュインプラントにとって最も一般的な手術用途の一つだからです。ヘルニアとは、臓器や組織が周囲の筋肉や結合組織の弱い部分を通って膨らむ状態のことです。例えば、aLLSurgicalメッシュは弱くなった部分を補強するために使用され、より良い回復結果を保証し、再発のリスクを低減します。

さらに、ヘルニアの修復は、世界中で最も一般的に行われている手術のひとつです。米国食品医薬品局（FDA）によると、年間約2,000万件のヘルニア手術が世界中で行われています。この手術件数の多さは、特に鼠径ヘルニア、臍ヘルニア、腹ヘルニアなどの手術に使用される外科用メッシュの需要を直接的に押し上げています。

外科用メッシュは、組織を長期的に補強する能力があるため、ヘルニア修復のゴールドスタンダードと考えられています。再発を防ぎ、回復を早めることができるため、ヘルニア修復術の80%にメッシュが使用されています。このようにヘルニア手術でメッシュインプラントが好まれることは、外科用メッシュ市場の成長に大きく寄与しています。

合併症と安全性への懸念

外科用メッシュに関連する合併症や安全性への懸念は、外科用メッシュ市場の成長を妨げると予想されます。これらの懸念は、メッシュの移動、感染、びらん、慢性疼痛、長期的な健康合併症などの問題を中心に展開され、これらすべてが患者の転帰を悪化させ、医療費の増加につながる可能性があります。外科用メッシュをめぐる有害事象や安全性に関する懸念の増大は、規制当局の精査や法的課題を促し、メッシュ製品の採用を遅らせる要因となっています。

メッシュの侵食は、メッシュ素材が劣化したり、元の位置から移動したりして、近くの組織や臓器に埋め込まれることで起こります。これは、感染、慢性疼痛、組織損傷などの深刻な合併症を引き起こす可能性があります。同様に、メッシュの移動とは、メッシュが意図した位置から移動することを指し、これもまた内部損傷を引き起こし、修正手術が必要になることがあります。

例えば、ヘルニア手術の5％から20％がメッシュの破損につながるという研究があります。British Medical Journal誌に掲載された研究によると、その割合は12％から30％です。このような合併症は再手術を必要とし、ヘルスケアコストと患者の罹患率の両方を増加させる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ヘルニアの罹患率の上昇
      • 外科用メッシュデザインにおける革新の台頭
    • 抑制要因
      • 合併症と安全性の懸念
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 特許分析
  • 規制分析
  • SWOT分析
  • アンメットニーズ

第6章 製品タイプ別

  • 吸収性外科用メッシュ
  • 非吸収性外科用メッシュ
  • 生物学的メッシュ
  • 合成メッシュ

第7章 素材の種類別

  • ポリプロピレン
  • ポリエステル
  • ポリテトラフルオロエチレン（PTFE）
  • その他

第8章 用途別

  • ヘルニア修復
  • 骨盤臓器脱の修復
  • 腹圧性尿失禁
  • その他

第9章 エンドユーザー別

  • 病院
  • 専門クリニック
  • 外来手術センター
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況・シェア分析
  • M&A分析

第12章 企業プロファイル

  • Johnson & Johnson
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
  • B. Braun SE
  • Medtronic plc
  • Becton, Dickinson and Company
  • CITEC
  • W. L. Gore & Associates, Inc.
  • Medcity Surgicals
  • Dolphin Sutures
  • Herniamesh S.r.l.
  • Advin Health Care（LIST NOT EXHAUSTIVE）

第13章 付録

目次
Product Code: MD8845

Overview

The global surgical mesh market reached US$ 1.90 billion in 2023 and is expected to reach US$ 3.22 billion by 2031, growing at a CAGR of 6.9% during the forecast period 2024-2031.

Surgical mesh is a medical device used in surgical procedures to provide additional support to weakened or damaged tissue. It is typically a flexible, sheet-like structure made from synthetic or biological materials and is designed to reinforce and stabilize tissues during healing. Surgical meshes are widely used in various surgical applications, including hernia repair, pelvic organ prolapse (POP) repair, stress urinary incontinence (SUI) treatment and other reconstructive surgeries. Meshes are available in various structures, such as monofilament, multifilament and composite meshes, to cater to specific surgical needs.

The surgical mesh market has witnessed substantial demand over the years owing to the rising hernia repairs, especially. For instance, according to the U.S. Food and Drug Administration (FDA), more than 1 million hernia repairs are performed each year in the United States, and worldwide these surgeries are estimated to top 20 million annually, these repairs involve the use of surgical mesh, making it the standard of care for hernia surgery, contributing to the increasing demand for surgical meshes.

Market Dynamics: Drivers & Restraints

Rising prevalence of hernias

The rising prevalence of hernias is significantly driving the surgical mesh market, as hernia repairs are one of the most common surgical applications for mesh implants. Hernia is a condition in which an organ or tissue bulges through a weak spot in the surrounding muscle or connective tissue. For instance, aLLSurgical mesh is used to reinforce the weakened area, ensuring better recovery outcomes and reducing the risk of recurrence.

Additionally, hernia repairs are among the most common types of surgeries performed worldwide. According to the U.S. Food and Drug Administration (FDA), annually, about 20 million hernia repairs are conducted globally. This high volume directly drives demand for surgical meshes used in these procedures, especially for inguinal, umbilical, and ventral hernias.

Surgical mesh is considered the gold standard for hernia repair due to its ability to provide long-term reinforcement to the tissue. 80% of all hernia repairs involve the use of mesh, as it helps prevent recurrence and speeds up recovery. This preference for mesh implants in hernia surgeries significantly contributes to the growth of the surgical mesh market.

Complications and safety concerns

Complications and safety concerns related to surgical mesh are expected to hamper the growth of the surgical mesh market. These concerns revolve around issues such as mesh migration, infection, erosion, chronic pain and long-term health complications, all of which can lead to negative patient outcomes and increased healthcare costs. The growing number of adverse events and safety concerns surrounding surgical meshes has prompted regulatory scrutiny and legal challenges, which can slow the adoption of mesh products.

Mesh erosion occurs when the mesh material degrades or moves from its original position, causing it to become embedded in nearby tissues or organs. This can lead to severe complications such as infection, chronic pain, and tissue damage. Similarly, mesh migration refers to the movement of the mesh from its intended placement, which can also cause internal damage and necessitate corrective surgery.

For instance, studies suggest that 5% to 20% of hernia operations result in mesh failure. According to a study in the British Medical Journal, the rate could be between 12% and 30%. These complications may require revision surgeries, which can increase both healthcare costs and patient morbidity.

Segment Analysis

The global surgical mesh market is segmented based on product type, material type, application, end-user and region.

Application:

The hernia repair segment is expected to dominate the global surgical mesh market share

The hernia repair segment holds a major portion of the surgical mesh market share and is expected to continue to hold a significant portion of the market share over the forecast period due to the established use of mesh in hernia repair surgeries and the superior outcomes provided by mesh-based procedures compared to traditional non-mesh surgeries. Hernia repair surgeries are the gold standard for reinforcing the weakened abdominal walls and preventing hernia recurrence. Thus, the market players are focusing on surgical mesh development due to its wide advantages.

For instance, in November 2024, Deep Blue Medical expanded its success of T-Line Hernia Mesh, a surgical product that helps prevent the recurrence of hernias after abdominal hernia repair surgery. Although the T-Line Mesh made its clinical debut just three years ago, it is already being used by about 45 clinical sites in the United States and over 8,000 of the novel extensions and lockstitches of the mesh have been implanted to date with no adverse events.

The shift towards minimally invasive hernia repair surgeries, such as laparoscopic and robot-assisted surgery, has contributed to the dominance of the hernia repair segment. Surgical meshes are ideal for use in these procedures because they are lightweight, flexible and can be easily inserted through small incisions.

For instance, laparoscopic hernia repair is becoming the preferred technique for many surgeons due to its lower complication rates and quicker recovery. According to the Global Hernia Society, the laparoscopic approach accounts for about 60-70% of hernia surgeries in developed countries, driving the demand for surgical meshes tailored for these procedures.

With the increasing awareness of hernias and the effectiveness of mesh-based surgeries, more patients are seeking treatment, contributing to the growing demand for hernia repairs using mesh. Additionally, improvements in healthcare access in emerging economies have increased the number of hernia surgeries being performed in those regions.

For instance, in June 2021, BG Medical., the manufacturer and distributor of the 21st Century SURGIMESH Platform honored Hernia Awareness Month by partnering with CQInsights to pioneer a new approach that delivers better outcomes for patients, with a larger mission to share sustainable solutions that improve healthcare for everyone.

North America is expected to hold a significant position in the global surgical mesh market

North America represents the largest share of the global surgical mesh market in terms of both revenue generation and market size. The U.S., in particular, is the largest market within the region, driven by a combination of high demand for surgeries, advanced healthcare technologies, and a well-established healthcare system.

North America, particularly the United States, has a high incidence of hernias due to factors such as an aging population, high obesity rates, and sedentary lifestyles. This has led to a large number of hernia repairs, most of which involve surgical mesh. For instance, according to Healthcare Cost and Utilization Project data and the US Food and Drug Administration, an estimated 611,000 ventral and 1 million inguinal hernia repairs are performed each year in the US.

North America has high levels of healthcare awareness and access, which leads to an increased number of surgeries involving surgical mesh. Patients are more likely to seek treatment for conditions like hernias, knowing that advanced treatments, such as mesh implants, are available. Thus, the market players are focusing on launching the surgical mesh with technological advancements.

For instance, in April 2024, ELA Bio commercially launched the OviTex Inguinal Hernia Repair (IHR) mesh in the US. The Pennsylvania-based firm has specifically designed the robotic-compatible OviTex IHR surgical mesh for use in laparoscopic and inguinal hernia repair. It comes in a three or four layer anatomically shaped device or a three-layer rectangular device.

Asia Pacific is growing at the fastest pace in the surgical mesh market

The Asia Pacific region is experiencing the fastest growth in the surgical mesh market. The rising rates of obesity in countries like China and India, combined with an increasing number of abdominal hernia cases, are driving the demand for hernia repair surgeries. Obesity is a key risk factor for hernias, and with lifestyle changes, these conditions are becoming more prevalent in the Asia Pacific region, creating a significant market opportunity for surgical meshes.

For instance, according to the World Health Organization (WHO), the prevalence of obesity in Asia is rising rapidly. According to the Chinese BMI classification for overweight and obesity, 34.8% of the study population were overweight and 14.1% were obese. This growing rate of obesity significantly contributes to the increasing number of hernia cases and surgeries requiring mesh.

The Asia Pacific region has witnessed significant investments in healthcare infrastructure, particularly in countries like India, China and South Korea, where hospitals, surgical centers and medical device manufacturers are modernizing and expanding. This has made advanced surgical treatments, including mesh-based procedures, more accessible to the growing population.

For instance, in October 2024, Park Hospital, a multi-specialty healthcare provider performed a complex robotic-assisted surgery to save a 45-year-old man from a complicated diaphragmatic hernia. Robotic-assisted surgery allowed to safely reduce the herniated organs back into the abdominal cavity and repair the diaphragm with a large mesh, ensuring a stable closure. This increases the demand for surgical mesh in the region.

Competitive Landscape

The major global players in the surgical mesh market include Johnson & Johnson, B. Braun SE, Medtronic plc, Becton, Dickinson and Company, CITEC, W. L. Gore & Associates, Inc., Medcity Surgicals, Dolphin Sutures, Herniamesh S.r.l., Advin Health Care and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Insights into clinical trials, product pipelines, and upcoming advancements.
  • Market Positioning: Analysis of product performance and growth potential for optimized strategies.
  • Real-World Evidence: Integration of patient feedback for enhanced product outcomes.
  • Physician Preferences: Insights into healthcare provider behaviors and adoption strategies.
  • Regulatory & Market Updates: Coverage of recent regulations, policies, and emerging technologies.
  • Competitive Insights: Analysis of market share, competitor strategies, and new entrants.
  • Pricing & Market Access: Review of pricing models, reimbursement trends, and access strategies.
  • Market Expansion: Strategies for entering new markets and forming partnerships.
  • Regional Opportunities: Identification of high-growth regions and investment prospects.
  • Supply Chain Optimization: Assessment of risks and distribution strategies.
  • Sustainability & Regulation: Focus on eco-friendly practices and regulatory changes.
  • Post-Market Surveillance: Enhanced safety and access through post-market data.
  • Value-Based Pricing: Insights into pharmacoeconomics and data-driven R&D decisions.

The global surgical mesh market report delivers a detailed analysis with 70 key tables, more than 66 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Material Type
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Hernias
      • 4.1.1.2. Rising Innovations in Surgical Mesh Designs
    • 4.1.2. Restraints
      • 4.1.2.1. Complications and Safety Concerns
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Patent Analysis
  • 5.5. Regulatory Analysis
  • 5.6. SWOT Analysis
  • 5.7. Unmet Needs

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Absorbable Surgical Mesh*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Non-Absorbable Surgical Mesh
  • 6.4. Biological Mesh
  • 6.5. Synthetic Mesh

7. By Material Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 7.1.2. Market Attractiveness Index, By Material Type
  • 7.2. Polypropylene*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Polyester
  • 7.4. Polytetrafluoroethylene (PTFE)
  • 7.5. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Hernia Repair*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Pelvic Organ Prolapse Repair
  • 8.4. Stress Urinary Incontinence
  • 8.5. Others

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Specialty Clinics
  • 9.4. Ambulatory Surgical Centers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Johnson & Johnson*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. B. Braun SE
  • 12.3. Medtronic plc
  • 12.4. Becton, Dickinson and Company
  • 12.5. CITEC
  • 12.6. W. L. Gore & Associates, Inc.
  • 12.7. Medcity Surgicals
  • 12.8. Dolphin Sutures
  • 12.9. Herniamesh S.r.l.
  • 12.10. Advin Health Care (LIST NOT EXHAUSTIVE )

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us